Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Americas Insomnia market is witnessing significant growth due to the rising prevalence of insomnia across North and South America. Lifestyle changes, high-stress levels, and the impact of modern technologies are contributing factors to the increased incidence of sleep disorders. As awareness of the importance of sleep health grows, more individuals are seeking solutions for insomnia, driving market expansion.
In the Americas, the pharmaceutical strides as insomnia treatment are still the predominant market players. Benzodiazepines like the sleep drugs as well as the non-benzodiazepine-receptor agonists and melatonin agonists still stand out as the prime approaches in the context of relieving cardinal insomnia symptoms. A kind of medication-oriented medical market has arisen, giving patients the choice between prescription and over-the-counter medications, both with the goal of treating insomnia.
One of the most distinguishable tendencies in the Americas’ insomnia market is a growing attention to non-pharmacological approaches for the treatment of insomnia. Cognitive Behavioral Therapy for Insomnia (CBT-I) as well as sleep hygiene education and relaxation techniques are gaining popularity among physicians and psychologists as efficacious methods which work either help or in conjunction with medications. Such as this development will define the increasing attention on the whole treatment that is connected with lifestyles of people for the disorders of insomnia.
The shape of the modern market is changing with regard to the adoption of digital healthcare for the sleep tracking and management. Wearable devices, mobile apps, and home automation system are what is being utilized to monitor sleep patterns, offer actionable insights, and prompt feedback. This digital tendency is the indication of the expansion of self-tracking and an eagerness for individuals to take the preemptive measures to improve sleep health.
Taking the lead in adopting telemedicine in the Americas market of the insomnia industry. The technology of telemedicine makes it possible to transmit information through various channels, including remote consultations with sleep specialists which is a crucial step in the diagnosis and treatment plans. This movement expands the access into sleep medicine and even facilitates individuals in the hidden zones and underserved areas of the world.
The research highlights that there is the increasing attention towards children insomnia problem within the country. This interest for sleep is more being stoked in children and teens with an increasing number of customized solutions becoming popular. Healthcare providers, who are already addressing the peculiarities of pediatric insomnia, are now drafting their own treatment options, directed especially for this age group.
The last couple of years have seen consumer preference for herbal and natural treatments to manage sleeping problems markedly increase. Natural medicinal plants, herbal teas and results-based products containing the like of valerian root, chamomile and lavender are getting popular. This is seen as a shift among consumers from rather chemical or pharmacological sleep remedies to more natural and holistic methods of treatment of sleep complaints.
Ongoing research in the Americas is exploring the complex relationship between insomnia and comorbidities such as anxiety, depression, and chronic health conditions. The market is responding with targeted interventions that consider the interconnected nature of sleep disorders and associated health issues. This research-driven trend is influencing the development of more tailored and effective treatments.
Stringent regulatory compliance requirements for insomnia treatments, including medications and digital health solutions, are shaping market dynamics. Manufacturers and service providers are focusing on adherence to safety standards and regulatory guidelines to ensure the reliability and safety of their products. This commitment to compliance enhances the market's credibility and fosters trust among healthcare professionals and patients.
Americas Insomnia Market Highlights:
Americas Insomnia Market Overview
The Americas Insomnia Market Size was valued at USD 2.28 Billion in 2023. The Global Americas Insomnia industry is projected to grow from USD 2.43 Billion in 2024 to USD 3.73 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.9% during the forecast period (2024 - 2032). Insomnia is disorder related to sleep, it creates difficulty in sleeping. The symptoms show dissatisfaction with sleep, fatigue, low energy, less concentration, low performance, irritation, change in moods and many more. There are three types of insomnia that is transient, acute and chronic. The transient insomnia is sleeping disorder that occurs for few days or few weeks. The acute insomnia may be experience when students have exams or a person has an interview. This is a short time difficulty in sleep that lasts for some weeks. While the chronic insomnia is long term disorder of sleep seen in people having regular shift timings on their jobs, unhealthy sleeping habits, clinical disorders and some other psychiatric issues or health issues and many more reasons associated. The prevalence rate of insomnia is very high and is increasing day by day. Worldwide millions of people are getting affected by the sleeping disorder. According to the CDC study, it says that American do sleep for 7hrs and 36min in working days while 40min more on non-working days. The insomnia is majorly seen in American women, data says that 24 percent of women have woken up with no well rest, while the 16 percent of men have experienced same. This percentage is very less in contrast to people who suffers from insomnia.
Study Objectives Americas Insomnia Market Research Report
- To provide the Detail Overview of American insomnia market.
- To provide In-depth market segmentation and sub segmentations.
- To provide insights about factors affecting the market growth
- To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide Competitive landscape and key players in the market.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to geography and countries- North America and South America.
- To provide country level analysis of the market with respect to the current market size and future prospective
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Americas Insomnia Market.
Key Players for Americas Insomnia Market
The number of local and global level players working for the insomnia are: Eisai, Co. (Japan), Pfizer, Inc. (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan), Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Flynn Pharma (UK), Johnson & Johnson (US), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), SkyePharma (UK), and Vanda Pharmaceuticals Inc. (US).
Segmentation
The Americas insomnia market is segmented on the basis of, types of therapy, drug formulation and by type of disease. On the basis of types of therapy market is segmented into pharmacological therapy and non-pharmacological therapy. On the basis of the pharmacological therapy is sub-segmented into Benzodiazepines, Non-benzodiazepines, Melatonin receptor agonists and others. Likewise on the basis of the non-pharmacological therapy is also sub-segmented into Relaxation therapy, Cognitive behavioural therapy, Sleep hygiene education, Stimulus Controls, Paradoxical intension and others. On the basis of drug formulation the drugs are being formulated in capsules, tablets and others. Whereas on the basis of type of disease it includes poor quality of sleep, sleep maintenance and others.
Regional Analysis
On regional basis the Americas insomnia market is segmented into two regions- North America and South America. Further North America is segmented into US and Canada. The North America region is experiencing more number of cases for insomnia. The cases are seen with unintentionally falling asleep and nodding while driving. The sleep related disorders are also seen because of the hypertension, cardio problems, cancer, depression, obesity and many more. It is estimated that near about 70 million US citizens are affected by insomnia.
The report for Americas Insomnia Market Research Report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience
- Manufacturing and packaging industries.
- Insomnia devices and drug manufacturers
- Biotechnology Companies
- Bio-Pharmaceutical Companies
- Research and Development (R&D) Companies
- Government Research Laboratories
- Medical Research Institutes
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
